Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

LXRX - Lexicon Pharmaceuticals Inc


IEX Last Trade
1.73
-0.070   -4.046%

Share volume: 3,307,233
Last Updated: Fri 30 Aug 2024 09:59:51 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$1.80
-0.07
-3.89%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30
Fiscal Quarter Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024
Report Date 2022-11-09 2023-03-03 2023-05-04 2023-08-04 2023-11-08 2024-03-25 2024-05-02 2024-08-02
Total revenue 39.000 K 28.000 K 24.000 K 317.000 K 162.000 K 701.000 K 1.130 M 1.647 M
Cost of revenue 0.000 0.000 0.000 8.000 K 7.000 K 70.000 K 31.000 K 166.000 K
Gross profit 39.000 K 28.000 K 24.000 K 309.000 K 155.000 K 631.000 K 1.099 M 1.481 M
    -28.21% -14.29% 1,187.50% -49.84% 307.10% 74.17% 34.76%  
Operating expenses 23.134 M 30.306 M 31.166 M 44.549 M 49.786 M 47.368 M 46.432 M 56.835 M
Selling general and admin 12.577 M 16.329 M 19.140 M 30.008 M 32.228 M 32.606 M 32.060 M 39.192 M
Research and development 10.557 M 13.977 M 12.026 M 14.541 M 17.558 M 14.762 M 14.372 M 17.643 M
Total expenses 23.134 M 30.306 M 31.166 M 44.557 M 49.793 M 47.438 M 46.463 M 57.001 M
    31.00% 2.84% 42.97% 11.75% -4.73% -2.06% 22.68%  
Operating income -23.095 M -30.278 M -31.142 M -44.240 M -49.631 M -46.737 M -45.333 M -55.354 M
Ebit -23.095 M -30.278 M -31.142 M -44.240 M -49.631 M -46.737 M -45.333 M -55.354 M
Pretax income -23.387 M -30.494 M -31.934 M -44.904 M -50.525 M -49.756 M -48.397 M -53.429 M
    30.39% 4.72% 40.62% 12.52% -1.52% -2.73% 10.40%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -23.387 M -30.494 M -31.934 M -44.904 M -50.525 M -49.756 M -48.397 M -53.429 M
    -30.39% -4.72% -40.62% -12.52% 1.52% 2.73% -10.40%  
Net income -23.387 M -30.494 M -31.934 M -44.904 M -50.525 M -49.756 M -48.397 M -53.429 M
    -30.39% -4.72% -40.62% -12.52% 1.52% 2.73% -10.40%